Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Prospective multicentre evaluation and refinement of an analysis tool for magnetic resonance spectroscopy of childhood cerebellar tumours.

Manias KA, Harris LM, Davies NP, Natarajan K, MacPherson L, Foster K, Brundler MA, Hargrave DR, Payne GS, Leach MO, Morgan PS, Auer D, Jaspan T, Arvanitis TN, Grundy RG, Peet AC.

Pediatr Radiol. 2018 Oct;48(11):1630-1641. doi: 10.1007/s00247-018-4182-0. Epub 2018 Jul 30.

2.

Perilesional apparent diffusion coefficient in the preoperative evaluation of glioma grade.

Yazdani M, Rumboldt Z, Tabesh A, Giglio P, Schiarelli C, Morgan PS, Spampinato MV.

Clin Imaging. 2018 Jul 7;52:88-94. doi: 10.1016/j.clinimag.2018.07.005. [Epub ahead of print]

PMID:
30032069
3.

Molecular, Pathological, Radiological, and Immune Profiling of Non-brainstem Pediatric High-Grade Glioma from the HERBY Phase II Randomized Trial.

Mackay A, Burford A, Molinari V, Jones DTW, Izquierdo E, Brouwer-Visser J, Giangaspero F, Haberler C, Pietsch T, Jacques TS, Figarella-Branger D, Rodriguez D, Morgan PS, Raman P, Waanders AJ, Resnick AC, Massimino M, Garrè ML, Smith H, Capper D, Pfister SM, Würdinger T, Tam R, Garcia J, Thakur MD, Vassal G, Grill J, Jaspan T, Varlet P, Jones C.

Cancer Cell. 2018 May 14;33(5):829-842.e5. doi: 10.1016/j.ccell.2018.04.004.

4.

Alterations in the microstructure of white matter in children and adolescents with Tourette syndrome measured using tract-based spatial statistics and probabilistic tractography.

Sigurdsson HP, Pépés SE, Jackson GM, Draper A, Morgan PS, Jackson SR.

Cortex. 2018 Jul;104:75-89. doi: 10.1016/j.cortex.2018.04.004. Epub 2018 Apr 12.

5.

Characterisation of insulin analogues therapeutically available to patients.

Adams GG, Meal A, Morgan PS, Alzahrani QE, Zobel H, Lithgo R, Kok MS, Besong DTM, Jiwani SI, Ballance S, Harding SE, Chayen N, Gillis RB.

PLoS One. 2018 Mar 29;13(3):e0195010. doi: 10.1371/journal.pone.0195010. eCollection 2018.

6.

Does tranexamic acid lead to changes in MRI measures of brain tissue health in patients with spontaneous intracerebral haemorrhage? Protocol for a MRI substudy nested within the double-blind randomised controlled TICH-2 trial.

Dineen RA, Pszczolkowski S, Flaherty K, Law ZK, Morgan PS, Roberts I, Werring DJ, Salman RA, England T, Bath PM, Sprigg N.

BMJ Open. 2018 Feb 3;8(2):e019930. doi: 10.1136/bmjopen-2017-019930. Erratum in: BMJ Open. 2018 Apr 20;8(4):e019930corr1.

7.

Phase II, Open-Label, Randomized, Multicenter Trial (HERBY) of Bevacizumab in Pediatric Patients With Newly Diagnosed High-Grade Glioma.

Grill J, Massimino M, Bouffet E, Azizi AA, McCowage G, Cañete A, Saran F, Le Deley MC, Varlet P, Morgan PS, Jaspan T, Jones C, Giangaspero F, Smith H, Garcia J, Elze MC, Rousseau RF, Abrey L, Hargrave D, Vassal G.

J Clin Oncol. 2018 Apr 1;36(10):951-958. doi: 10.1200/JCO.2017.76.0611. Epub 2018 Feb 7.

PMID:
29412784
8.

Metadata Correction: Brain Activation in Response to Personalized Behavioral and Physiological Feedback From Self-Monitoring Technology: Pilot Study.

Whelan ME, Morgan PS, Sherar LB, Kingsnorth AP, Magistro D, Esliger DW.

J Med Internet Res. 2017 Dec 21;19(12):e430. doi: 10.2196/jmir.9426.

9.

Brain Activation in Response to Personalized Behavioral and Physiological Feedback From Self-Monitoring Technology: Pilot Study.

Whelan ME, Morgan PS, Sherar LB, Kingsnorth AP, Magistro D, Esliger DW.

J Med Internet Res. 2017 Nov 8;19(11):e384. doi: 10.2196/jmir.8890. Erratum in: J Med Internet Res. 2017 Dec 21;19(12 ):e430. http://dx.doi.org/10.2196/jmir.9426.

10.

Application of pattern recognition techniques for classification of pediatric brain tumors by in vivo 3T 1 H-MR spectroscopy-A multi-center study.

Zarinabad N, Abernethy LJ, Avula S, Davies NP, Rodriguez Gutierrez D, Jaspan T, MacPherson L, Mitra D, Rose HEL, Wilson M, Morgan PS, Bailey S, Pizer B, Arvanitis TN, Grundy RG, Auer DP, Peet A.

Magn Reson Med. 2018 Apr;79(4):2359-2366. doi: 10.1002/mrm.26837. Epub 2017 Aug 8.

11.

Glargine and degludec: Solution behaviour of higher dose synthetic insulins.

Adams GG, Alzahrani Q, Jiwani SI, Meal A, Morgan PS, Coffey F, Kok S, Rowe AJ, Harding SE, Chayen N, Gillis RB.

Sci Rep. 2017 Aug 4;7(1):7287. doi: 10.1038/s41598-017-06642-w.

12.

Activation induced changes in GABA: Functional MRS at 7T with MEGA-sLASER.

Chen C, Sigurdsson HP, Pépés SE, Auer DP, Morris PG, Morgan PS, Gowland PA, Jackson SR.

Neuroimage. 2017 Aug 1;156:207-213. doi: 10.1016/j.neuroimage.2017.05.044. Epub 2017 May 19.

PMID:
28533117
13.

An international survey of MRI qualification and certification frameworks with an emphasis on identifying elements of good practice.

Castillo J, Caruana CJ, Morgan PS, Westbrook C, Mizzi A.

Radiography (Lond). 2017 Feb;23(1):e8-e13. doi: 10.1016/j.radi.2016.08.009. Epub 2016 Sep 7.

PMID:
28290357
14.

Can functional magnetic resonance imaging studies help with the optimization of health messaging for lifestyle behavior change? A systematic review.

Whelan ME, Morgan PS, Sherar LB, Orme MW, Esliger DW.

Prev Med. 2017 Jun;99:185-196. doi: 10.1016/j.ypmed.2017.02.004. Epub 2017 Feb 16. Review.

PMID:
28214544
15.

The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T.

Samaraweera AP, Clarke MA, Whitehead A, Falah Y, Driver ID, Dineen RA, Morgan PS, Evangelou N.

J Neuroimaging. 2017 Jan;27(1):114-121. doi: 10.1111/jon.12367. Epub 2016 Jun 14.

PMID:
27300318
16.

Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.

Jaspan T, Morgan PS, Warmuth-Metz M, Sanchez Aliaga E, Warren D, Calmon R, Grill J, Hargrave D, Garcia J, Zahlmann G.

AJNR Am J Neuroradiol. 2016 Sep;37(9):1581-7. doi: 10.3174/ajnr.A4782. Epub 2016 Apr 28.

17.

The first step for neuroimaging data analysis: DICOM to NIfTI conversion.

Li X, Morgan PS, Ashburner J, Smith J, Rorden C.

J Neurosci Methods. 2016 May 1;264:47-56. doi: 10.1016/j.jneumeth.2016.03.001. Epub 2016 Mar 2.

PMID:
26945974
18.

Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions.

Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C, Jaspan T, Morris P, Morgan PS, Evangelou N.

Mult Scler. 2016 Sep;22(10):1289-96. doi: 10.1177/1352458515616700. Epub 2015 Dec 10.

PMID:
26658816
19.

Premonitory urges are associated with decreased grey matter thickness within the insula and sensorimotor cortex in young people with Tourette syndrome.

Draper A, Jackson GM, Morgan PS, Jackson SR.

J Neuropsychol. 2016 Mar;10(1):143-53. doi: 10.1111/jnp.12089. Epub 2015 Nov 5.

20.

Assessment of bone marrow-derived Cellular Therapy in progressive Multiple Sclerosis (ACTiMuS): study protocol for a randomised controlled trial.

Rice CM, Marks DI, Ben-Shlomo Y, Evangelou N, Morgan PS, Metcalfe C, Walsh P, Kane NM, Guttridge MG, Miflin G, Blackmore S, Sarkar P, Redondo J, Owen D, Cottrell DA, Wilkins A, Scolding NJ.

Trials. 2015 Oct 14;16:463. doi: 10.1186/s13063-015-0953-1.

21.

Proton magnetic resonance spectroscopy and outcome in term neonates with chorioamnionitis.

Johnson CB, Jenkins DD, Bentzley JP, Lambert D, Hope K, Rollins LG, Morgan PS, Brown T, Ramakrishnan V, Mulvihill DM, Katikaneni LD.

J Perinatol. 2015 Dec;35(12):1030-6. doi: 10.1038/jp.2015.121. Epub 2015 Oct 1.

22.

Assessment of the performance of small field of view gamma cameras for sentinel node imaging.

Ng AH, Clay D, Blackshaw PE, Bugby SL, Morgan PS, Lees JE, Perkins AC.

Nucl Med Commun. 2015 Nov;36(11):1134-42. doi: 10.1097/MNM.0000000000000377.

PMID:
26352214
23.

Autism spectrum disorder 101: A primer for pediatric otolaryngologists.

Biyani S, Morgan PF, Hotchkiss K, Cecchini M, Derkay CS.

Int J Pediatr Otorhinolaryngol. 2015 Jun;79(6):798-802. doi: 10.1016/j.ijporl.2015.04.006. Epub 2015 Apr 11. Review. Erratum in: Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2487. Morgan, Patrick S [corrected to Morgan, Patrick F].

PMID:
25912683
24.

Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain.

Grech-Sollars M, Hales PW, Miyazaki K, Raschke F, Rodriguez D, Wilson M, Gill SK, Banks T, Saunders DE, Clayden JD, Gwilliam MN, Barrick TR, Morgan PS, Davies NP, Rossiter J, Auer DP, Grundy R, Leach MO, Howe FA, Peet AC, Clark CA.

NMR Biomed. 2015 Apr;28(4):468-85. doi: 10.1002/nbm.3269.

25.

Histologic validation of locus coeruleus MRI contrast in post-mortem tissue.

Keren NI, Taheri S, Vazey EM, Morgan PS, Granholm AC, Aston-Jones GS, Eckert MA.

Neuroimage. 2015 Jun;113:235-45. doi: 10.1016/j.neuroimage.2015.03.020. Epub 2015 Mar 17.

26.

Increased GABA contributes to enhanced control over motor excitability in Tourette syndrome.

Draper A, Stephenson MC, Jackson GM, Pépés S, Morgan PS, Morris PG, Jackson SR.

Curr Biol. 2014 Oct 6;24(19):2343-7. doi: 10.1016/j.cub.2014.08.038. Epub 2014 Sep 25.

27.

The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.

Schwarz ST, Afzal M, Morgan PS, Bajaj N, Gowland PA, Auer DP.

PLoS One. 2014 Apr 7;9(4):e93814. doi: 10.1371/journal.pone.0093814. eCollection 2014.

28.

Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis.

Schwarz ST, Abaei M, Gontu V, Morgan PS, Bajaj N, Auer DP.

Neuroimage Clin. 2013 Oct 14;3:481-8. doi: 10.1016/j.nicl.2013.10.006. eCollection 2013.

29.

Improved visualization of perfusion defects by respiratory-gated SPECT: a phantom simulation study.

Darwesh RM, Shin E, Morgan PS, Perkins AC.

Nucl Med Commun. 2014 Feb;35(2):189-96. doi: 10.1097/MNM.0000000000000015.

PMID:
24217430
30.

Adjuvant chemotherapy for brain tumors delivered via a novel intra-cavity moldable polymer matrix.

Rahman CV, Smith SJ, Morgan PS, Langmack KA, Clarke PA, Ritchie AA, Macarthur DC, Rose FR, Shakesheff KM, Grundy RG, Ruman Rahman.

PLoS One. 2013 Oct 14;8(10):e77435. doi: 10.1371/journal.pone.0077435. eCollection 2013.

31.

Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain.

Mistry N, Dixon J, Tallantyre E, Tench C, Abdel-Fahim R, Jaspan T, Morgan PS, Morris P, Evangelou N.

JAMA Neurol. 2013 May;70(5):623-8. doi: 10.1001/jamaneurol.2013.1405.

PMID:
23529352
32.

Increased iron accumulation occurs in the earliest stages of demyelinating disease: an ultra-high field susceptibility mapping study in Clinically Isolated Syndrome.

Al-Radaideh AM, Wharton SJ, Lim SY, Tench CR, Morgan PS, Bowtell RW, Constantinescu CS, Gowland PA.

Mult Scler. 2013 Jun;19(7):896-903. doi: 10.1177/1352458512465135. Epub 2012 Nov 8.

PMID:
23139386
33.

Volitional reduction of anterior cingulate cortex activity produces decreased cue craving in smoking cessation: a preliminary real-time fMRI study.

Li X, Hartwell KJ, Borckardt J, Prisciandaro JJ, Saladin ME, Morgan PS, Johnson KA, Lematty T, Brady KT, George MS.

Addict Biol. 2013 Jul;18(4):739-48. doi: 10.1111/j.1369-1600.2012.00449.x. Epub 2012 Mar 28.

34.

Focal multiple sclerosis lesions abound in 'normal appearing white matter'.

Mistry N, Tallantyre EC, Dixon JE, Galazis N, Jaspan T, Morgan PS, Morris P, Evangelou N.

Mult Scler. 2011 Nov;17(11):1313-23. doi: 10.1177/1352458511415305. Epub 2011 Jul 25.

PMID:
21788249
35.

Cerebral perfusion in chronic stroke: implications for lesion-symptom mapping and functional MRI.

Richardson JD, Baker JM, Morgan PS, Rorden C, Bonilha L, Fridriksson J.

Behav Neurol. 2011;24(2):117-22. doi: 10.3233/BEN-2011-0283.

36.

T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease.

Schwarz ST, Rittman T, Gontu V, Morgan PS, Bajaj N, Auer DP.

Mov Disord. 2011 Aug 1;26(9):1633-8. doi: 10.1002/mds.23722. Epub 2011 Apr 12. Erratum in: Mov Disord. 2012 Feb;27(2):335.

PMID:
21491489
37.

Hippocampal atrophy in temporal lobe epilepsy: the 'generator' and 'receiver'.

Bonilha L, Halford JJ, Morgan PS, Edwards JC.

Acta Neurol Scand. 2012 Feb;125(2):105-10. doi: 10.1111/j.1600-0404.2011.01510.x. Epub 2011 Apr 6.

PMID:
21470191
38.

Compensatory neural reorganization in Tourette syndrome.

Jackson SR, Parkinson A, Jung J, Ryan SE, Morgan PS, Hollis C, Jackson GM.

Curr Biol. 2011 Apr 12;21(7):580-5. doi: 10.1016/j.cub.2011.02.047.

39.

Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions.

Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, Evangelou N.

Neurology. 2011 Feb 8;76(6):534-9. doi: 10.1212/WNL.0b013e31820b7630.

40.

Plaque hemorrhage is a marker of thromboembolic activity in patients with symptomatic carotid disease.

Altaf N, Goode SD, Beech A, Gladman JR, Morgan PS, MacSweeney ST, Auer DP.

Radiology. 2011 Feb;258(2):538-45. doi: 10.1148/radiol.10100198. Epub 2010 Dec 16.

PMID:
21163919
41.

Intermittent "real-time" fMRI feedback is superior to continuous presentation for a motor imagery task: a pilot study.

Johnson KA, Hartwell K, LeMatty T, Borckardt J, Morgan PS, Govindarajan K, Brady K, George MS.

J Neuroimaging. 2012 Jan;22(1):58-66. doi: 10.1111/j.1552-6569.2010.00529.x. Epub 2010 Oct 26.

42.

Mapping anterior temporal lobe language areas with fMRI: a multicenter normative study.

Binder JR, Gross WL, Allendorfer JB, Bonilha L, Chapin J, Edwards JC, Grabowski TJ, Langfitt JT, Loring DW, Lowe MJ, Koenig K, Morgan PS, Ojemann JG, Rorden C, Szaflarski JP, Tivarus ME, Weaver KE.

Neuroimage. 2011 Jan 15;54(2):1465-75. doi: 10.1016/j.neuroimage.2010.09.048. Epub 2010 Sep 25.

43.

3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions.

Tallantyre EC, Morgan PS, Dixon JE, Al-Radaideh A, Brookes MJ, Morris PG, Evangelou N.

J Magn Reson Imaging. 2010 Oct;32(4):971-7. doi: 10.1002/jmri.22115.

PMID:
20882628
44.

Impaired speech repetition and left parietal lobe damage.

Fridriksson J, Kjartansson O, Morgan PS, Hjaltason H, Magnusdottir S, Bonilha L, Rorden C.

J Neurosci. 2010 Aug 18;30(33):11057-61. doi: 10.1523/JNEUROSCI.1120-10.2010.

45.

Fractional anisotropy changes after several weeks of daily left high-frequency repetitive transcranial magnetic stimulation of the prefrontal cortex to treat major depression.

Kozel FA, Johnson KA, Nahas Z, Nakonezny PA, Morgan PS, Anderson BS, Kose S, Li X, Lim KO, Trivedi MH, George MS.

J ECT. 2011 Mar;27(1):5-10. doi: 10.1097/YCT.0b013e3181e6317d.

46.

How common is brain atrophy in patients with medial temporal lobe epilepsy?

Bonilha L, Elm JJ, Edwards JC, Morgan PS, Hicks C, Lozar C, Rumboldt Z, Roberts DR, Rorden C, Eckert MA.

Epilepsia. 2010 Sep;51(9):1774-9. doi: 10.1111/j.1528-1167.2010.02576.x.

47.

A quantitative analysis of the benefits of cardiac gating in practical diffusion tensor imaging of the brain.

Habib J, Auer DP, Morgan PS.

Magn Reson Med. 2010 Apr;63(4):1098-103. doi: 10.1002/mrm.22232.

48.

Extrahippocampal gray matter loss and hippocampal deafferentation in patients with temporal lobe epilepsy.

Bonilha L, Edwards JC, Kinsman SL, Morgan PS, Fridriksson J, Rorden C, Rumboldt Z, Roberts DR, Eckert MA, Halford JJ.

Epilepsia. 2010 Apr;51(4):519-28. doi: 10.1111/j.1528-1167.2009.02506.x. Epub 2010 Feb 12.

49.

Inverse effects of oxytocin on attributing mental activity to others in depressed and healthy subjects: a double-blind placebo controlled FMRI study.

Pincus D, Kose S, Arana A, Johnson K, Morgan PS, Borckardt J, Herbsman T, Hardaway F, George MS, Panksepp J, Nahas Z.

Front Psychiatry. 2010 Oct 12;1:134. doi: 10.3389/fpsyt.2010.00134. eCollection 2010.

50.

Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease.

Turan TN, Bonilha L, Morgan PS, Adams RJ, Chimowitz MI.

J Neuroimaging. 2011 Apr;21(2):e159-61. doi: 10.1111/j.1552-6569.2009.00442.x.

PMID:
19909397

Supplemental Content

Loading ...
Support Center